- 专利标题: MULTI-LEVEL SPECIFIC TARGETING OF CANCER CELLS
-
申请号: US15695392申请日: 2017-09-05
-
公开(公告)号: US20180002394A1公开(公告)日: 2018-01-04
- 发明人: Waldemar Debinski , Hetal Pandya , Denise Gibo
- 申请人: Wake Forest University Health Sciences
- 主分类号: C07K14/54
- IPC分类号: C07K14/54 ; C07K14/005 ; C07K14/195 ; C07K14/21 ; C07K19/00 ; A61K47/64 ; G01N33/68 ; C07K14/34 ; G01N33/50 ; G01N33/532 ; A61K38/00
摘要:
A compound comprising, in combination: a cell surface binding ligand or internalizing factor, such as an IL-13Rα2 binding ligand; at least one effector molecule (e.g., one, two, three or more effector molecules); optionally but preferably, a cytosol localization element covalently coupled between said binding ligand and said at least one effector molecule; and a subcellular compartment localization signal element covalently coupled between said binding ligand and said at least one effector molecule (and preferably with said cytosol localization element between said binding ligand and said subcellular compartment localization signal element). Methods of using such compounds and formulations containing the same are also described.
公开/授权文献
信息查询